ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

DCT Board Okays Recompetitions

June 21, 1985

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009